Publications by authors named "Vijender Panduga"

Claim this Profile
A
A drug-drug interaction study and physiologically based pharmacokinetic modelling to assess the effect of an oral 5-lipoxygenase activating protein inhibitor on the pharmacokinetics of oral midazolam.
Jane Knöchel, Vijender Panduga, Karin Nelander, Maria Heijer, Eva-Lotte Lindstedt

Br J Clin Pharmacol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scaffold Morphing To Identify Novel DprE1 Inhibitors with Antimycobacterial Activity.
Manjunatha M R, Radha Shandil, Manoranjan Panda, Claire Sadler, Anisha Ambady, Vijender Panduga

ACS Med Chem Lett· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the metabolism, bioactivation and pharmacokinetics of triaminopyrimidine analogs toward selection of a potential candidate for antimalarial therapy.
Abhishek Srivastava, Vijender Panduga, Ramanatha Saralaya, Prabhakar K R, Shahul Hameed

Xenobiotica· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ipratropium is 'luminally recycled' by an inter-play between apical uptake and efflux transporters in Calu-3 bronchial epithelial cell layers.
Vijender Panduga, Michael J Stocks, Cynthia Bosquillon

Int J Pharm· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Imidazo[1,2-a]pyridine Ethers and Squaramides as Selective and Potent Inhibitors of Mycobacterial Adenosine Triphosphate (ATP) Synthesis.
Subramanyam J Tantry, Shankar D Markad, Vikas Shinde, Jyothi Bhat, Gayathri Balakrishnan, Vijender Panduga

J Med Chem· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In silico-based high-throughput screen for discovery of novel combinations for tuberculosis treatment.
Ragini Singh, Vasanthi Ramachandran, Radha Shandil, Sreevalli Sharma, Swati Khandelwal, Vijender Panduga

Antimicrob Agents Chemother· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triaminopyrimidine is a fast-killing and long-acting antimalarial clinical candidate.
Shahul Hameed P, Suresh Solapure, Vikas Patil, Philipp P Henrich, Pamela A Magistrado, Vijender Panduga

Nat Commun· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of pyrrolamides as mycobacterial GyrB ATPase inhibitors: structure-activity relationship and in vivo efficacy in a mouse model of tuberculosis.
Shahul Hameed P, Suresh Solapure, Kakoli Mukherjee, Vrinda Nandi, David Waterson, Vijender Panduga

Antimicrob Agents Chemother· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
1,4-azaindole, a potential drug candidate for treatment of tuberculosis.
Monalisa Chatterji, Radha Shandil, M R Manjunatha, Suresh Solapure, Vasanthi Ramachandran, Vijender Panduga

Antimicrob Agents Chemother· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N-aryl-2-aminobenzimidazoles: novel, efficacious, antimalarial lead compounds.
Sreekanth Ramachandran, Shahul Hameed P, Abhishek Srivastava, Gajanan Shanbhag, Sapna Morayya, Vijender Panduga

J Med Chem· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lead optimization of 1,4-azaindoles as antimycobacterial agents.
Pravin S Shirude, Radha K Shandil, M R Manjunatha, Claire Sadler, Manoranjan Panda, Vijender Panduga

J Med Chem· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aminoazabenzimidazoles, a novel class of orally active antimalarial agents.
Shahul Hameed P, Murugan Chinnapattu, Gajanan Shanbag, Praveena Manjrekar, Krishna Koushik, Vijender Panduga

J Med Chem· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benzimidazoles: novel mycobacterial gyrase inhibitors from scaffold morphing.
Shahul Hameed P, Anandkumar Raichurkar, Prashanti Madhavapeddi, Sreenivasaiah Menasinakai, Sreevalli Sharma, Vijender Panduga

ACS Med Chem Lett· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel N-linked aminopiperidine-based gyrase inhibitors with improved hERG and in vivo efficacy against Mycobacterium tuberculosis.
Shahul Hameed P, Vikas Patil, Suresh Solapure, Umender Sharma, Prashanti Madhavapeddi, Vijender Panduga

J Med Chem· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
4
4-aminoquinolone piperidine amides: noncovalent inhibitors of DprE1 with long residence time and potent antimycobacterial activity.
Maruti Naik, Vaishali Humnabadkar, Subramanyam J Tantry, Manoranjan Panda, Ashwini Narayan, Vijender Panduga

J Med Chem· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Azaindoles: noncovalent DprE1 inhibitors from scaffold morphing efforts, kill Mycobacterium tuberculosis and are efficacious in vivo.
Pravin S Shirude, Radha Shandil, Claire Sadler, Maruti Naik, Vinayak Hosagrahara, Vijender Panduga

J Med Chem· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thiazolopyridine ureas as novel antitubercular agents acting through inhibition of DNA Gyrase B.
Manoj G Kale, Anandkumar Raichurkar, Shahul Hameed P, David Waterson, David McKinney, Vijender Panduga

J Med Chem· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro and in vivo efficacy of β-lactams against replicating and slowly growing/nonreplicating Mycobacterium tuberculosis.
Suresh Solapure, Neela Dinesh, Radha Shandil, Vasanthi Ramachandran, Sreevalli Sharma, Vijender Panduga

Antimicrob Agents Chemother· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of repeated dosing on rifampin exposure in BALB/c mice.
Vinayak Hosagrahara, Jitendar Reddy, Samit Ganguly, Vijender Panduga, Vijaykamal Ahuja

Eur J Pharm Sci· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of coadministration of moxifloxacin and rifampin on Mycobacterium tuberculosis in a murine aerosol infection model.
V Balasubramanian, S Solapure, S Gaonkar, K N Mahesh Kumar, R K Shandil, Vijender Panduga

Antimicrob Agents Chemother· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis